Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.
Badhey N, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Addo TA, Haagen D, Abdel-Karim AR, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES. Badhey N, et al. Among authors: addo ta. Catheter Cardiovasc Interv. 2010 Aug 1;76(2):263-9. doi: 10.1002/ccd.22438. Catheter Cardiovasc Interv. 2010. PMID: 20665875 Clinical Trial.
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
Brilakis ES, Lichtenwalter C, Abdel-karim AR, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S. Brilakis ES, et al. JACC Cardiovasc Interv. 2011 Feb;4(2):176-82. doi: 10.1016/j.jcin.2010.10.003. JACC Cardiovasc Interv. 2011. PMID: 21349456 Free article. Clinical Trial.
Recurrent cardiovascular events with paclitaxel-eluting versus bare-metal stents in saphenous vein graft lesions: insights from the SOS (Stenting of Saphenous Vein Grafts) trial.
Michael TT, Abdel-karim AR, Papayannis A, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES. Michael TT, et al. J Invasive Cardiol. 2011 Jun;23(6):216-9. J Invasive Cardiol. 2011. PMID: 21646644 Free article.
Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trial.
Jeroudi OM, Abdel-Karim AR, Michael TT, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Raghunathan D, DaSilva M, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES. Jeroudi OM, et al. EuroIntervention. 2011 Dec;7(8):948-54. doi: 10.4244/EIJV7I8A150. EuroIntervention. 2011. PMID: 22157480 Free article. Clinical Trial.
Prevalence and outcomes of intermediate saphenous vein graft lesions: findings from the stenting of saphenous vein grafts randomized-controlled trial.
Abdel-Karim AR, Da Silva M, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Makke L, Jeroudi OM, Raghunathan D, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES. Abdel-Karim AR, et al. Int J Cardiol. 2013 Oct 3;168(3):2468-73. doi: 10.1016/j.ijcard.2013.03.006. Epub 2013 Apr 3. Int J Cardiol. 2013. PMID: 23561918 Clinical Trial.
Paclitaxel-eluting vs. bare metal stent implantation in saphenous vein graft lesions: Very long-term follow-up of the SOS (Stenting of Saphenous vein grafts) trial.
Sosa A, Chao H, Guerra A, Han H, Christopoulos G, Christakopoulos GE, Tarar MN, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Banerjee S, Brilakis ES. Sosa A, et al. Int J Cardiol. 2015;186:261-3. doi: 10.1016/j.ijcard.2015.03.267. Epub 2015 Mar 20. Int J Cardiol. 2015. PMID: 25828130 No abstract available.
Impact of Chronic Total Occlusions and Coronary Revascularization on All-Cause Mortality and the Incidence of Ventricular Arrhythmias in Patients With Ischemic Cardiomyopathy.
Raja V, Wiegn P, Obel O, Christakopoulos G, Christopoulos G, Rangan BV, Roesle M, Abdullah SM, Luna M, Addo T, Ayers C, Garcia S, de Lemos JA, Banerjee S, Brilakis ES. Raja V, et al. Am J Cardiol. 2015 Nov 1;116(9):1358-62. doi: 10.1016/j.amjcard.2015.07.057. Epub 2015 Aug 14. Am J Cardiol. 2015. PMID: 26341182
Optical coherence tomography findings after chronic total occlusion interventions: Insights from the "AngiographiC evaluation of the everolimus-eluting stent in chronic Total occlusions" (ACE-CTO) study (NCT01012869).
Sherbet DP, Christopoulos G, Karatasakis A, Danek BA, Kotsia A, Navara R, Michael TT, Roesle M, Rangan BV, Haagen D, Garcia S, Maniu C, Pershad A, Abdullah SM, Hastings JL, Kumbhani DJ, Luna M, Addo T, Banerjee S, Brilakis ES. Sherbet DP, et al. Cardiovasc Revasc Med. 2016 Oct-Nov;17(7):444-449. doi: 10.1016/j.carrev.2016.04.002. Epub 2016 Apr 15. Cardiovasc Revasc Med. 2016. PMID: 27133499
32 results